Journal of Cancer Research and Therapeutics Close
 

Figure 2: (a) Fluorescence images of Hoechst dye labeled A549 cancer and clone cells without (i-iv) or with verapamil (v-viii) treatment by confocal microscopy at 40× magnification magnification; arrows show cells with low fluorescence and dye efflux, (b) mean fluorescent intensity per cell in A549 cancer and clone cells; *significantly different when compared to cells without verapamil treatment (P < 0.001), (c) Percentage of Hoechst 33342−/low in A549 cancer cells and clones. *Significantly different when compared to A549 cancer cells (P < 0.001)

Figure 2: (a) Fluorescence images of Hoechst dye labeled A549 cancer and clone cells without (i-iv) or with verapamil (v-viii) treatment by confocal microscopy at 40× magnification magnification; arrows show cells with low fluorescence and dye efflux, (b) mean fluorescent intensity per cell in A549 cancer and clone cells; *significantly different when compared to cells without verapamil treatment (<i>P</i> < 0.001), (c) Percentage of Hoechst 33342<sup>−/low</sup> in A549 cancer cells and clones. *Significantly different when compared to A549 cancer cells (<i>P</i> < 0.001)